Detalles de la búsqueda
1.
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF.
Am Heart J
; 213: 35-46, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31128503
2.
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: insights from the GARFIELD-AF registry.
Eur Heart J
; 39(6): 464-473, 2018 02 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-29281086
3.
Models for zero-inflated, correlated count data with extra heterogeneity: when is it too complex?
Stat Med
; 36(2): 345-361, 2017 01 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-27734514
4.
Two-year outcomes of patients with newly diagnosed atrial fibrillation: results from GARFIELD-AF.
Eur Heart J
; 37(38): 2882-2889, 2016 Oct 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-27357359
5.
Apixaban with antiplatelet therapy after acute coronary syndrome.
N Engl J Med
; 365(8): 699-708, 2011 Aug 25.
Artículo
en Inglés
| MEDLINE | ID: mdl-21780946
6.
Extent of coronary artery disease and outcomes after ticagrelor administration in patients with an acute coronary syndrome: Insights from the PLATelet inhibition and patient Outcomes (PLATO) trial.
Am Heart J
; 168(1): 68-75.e2, 2014 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-24952862
7.
Clinical Outcomes in Older Patients with Atrial Fibrillation: Insights from the GARFIELD-AF Registry.
Am J Med
; 137(2): 128-136.e13, 2024 Feb.
Artículo
en Inglés
| MEDLINE | ID: mdl-37918777
8.
Effect of ticagrelor on the outcomes of patients with prior coronary artery bypass graft surgery: insights from the PLATelet inhibition and patient outcomes (PLATO) trial.
Am Heart J
; 166(3): 474-80, 2013 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-24016496
9.
Determinants and clinical outcomes of patients who refused anticoagulation: findings from the global GARFIELD-AF registry.
Open Heart
; 10(1)2023 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37169491
10.
Enoxaparin for symptomatic COVID-19 managed in the ambulatory setting: An individual patient level analysis of the OVID and ETHIC trials.
Thromb Res
; 230: 27-32, 2023 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-37625200
11.
Characterization of dyspnoea in PLATO study patients treated with ticagrelor or clopidogrel and its association with clinical outcomes.
Eur Heart J
; 32(23): 2945-53, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21804104
12.
Thromboprophylactic low-molecular-weight heparin versus standard of care in unvaccinated, at-risk outpatients with COVID-19 (ETHIC): an open-label, multicentre, randomised, controlled, phase 3b trial.
Lancet Haematol
; 9(8): e594-e604, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35779560
13.
Characteristics of patients with atrial fibrillation prescribed edoxaban in Belgium and The Netherlands: insights from the ETNA-AF-Europe study.
Acta Cardiol
; 76(4): 431-439, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33406996
14.
Risks associated with discontinuation of oral anticoagulation in newly diagnosed patients with atrial fibrillation: Results from the GARFIELD-AF Registry.
J Thromb Haemost
; 19(9): 2322-2334, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-34060704
15.
Bleeding and related mortality with NOACs and VKAs in newly diagnosed atrial fibrillation: results from the GARFIELD-AF registry.
Blood Adv
; 5(4): 1081-1091, 2021 02 23.
Artículo
en Inglés
| MEDLINE | ID: mdl-33606006
16.
GARFIELD-AF: a worldwide prospective registry of patients with atrial fibrillation at risk of stroke.
Future Cardiol
; 17(1): 19-38, 2021 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-32696663
17.
Apixaban, an oral, direct, selective factor Xa inhibitor, in combination with antiplatelet therapy after acute coronary syndrome: results of the Apixaban for Prevention of Acute Ischemic and Safety Events (APPRAISE) trial.
Circulation
; 119(22): 2877-85, 2009 Jun 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-19470889
18.
Torcetrapib produces endothelial dysfunction independent of cholesteryl ester transfer protein inhibition.
J Cardiovasc Pharmacol
; 55(5): 459-68, 2010 May.
Artículo
en Inglés
| MEDLINE | ID: mdl-20051879
19.
Use of the Actiwatch-Mini® in dog safety studies as an early indicator for drug-induced behavioural changes.
J Pharmacol Toxicol Methods
; 104: 106896, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-32622755
20.
Echocardiographic and hemodynamic indices of myocardial contractility simultaneously evaluated in telemetered beagle dogs: A HESI-sponsored cross-company evaluation.
J Pharmacol Toxicol Methods
; 105: 106897, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-32663523